BackElicio Therapeutics Overview

Elicio Therapeutics Total Liabilities

Elicio Therapeutics's total liabilities is $21M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$20.75M
↓ 15.22% YoYΔ $-3.72M vs prior year quarter

Peer trimmed avg / median

Loading

Elicio Therapeutics Total Liabilities History

Loading

Elicio Therapeutics vs. peers: Total Liabilities Comparison

Loading

Elicio Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Elicio Therapeutics (ELTX) FAQ

As of the most recent data (September 2026), ELTX shows a total liabilities of $21M. That compares with $24M in the prior-year period — down 15.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELTX's total liabilities is now $21M (was $24M) — a 15.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Elicio Therapeutics is outperforming or lagging.

Tracking ELTX's total liabilities over time shows whether Elicio Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $24M in the prior-year period — down 15.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Elicio Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $21M) with ownership activity and broader fundamentals.